Management

Ex-Baring partner to raise $250 mn

Corpus may touch $500 mn if infrastructure included - PE investments set to flood power sector - Emerging mkts take lion"s share in global PE activity in H1 - Interest in healthcare mounts among PE, VC players - Aditya Birla PE Fund to pick up 0.5% in BSE - LifeCell plans to set up facilities in West Asia - Life and times of a Pi N ‘Subbu’ Subramaniam, who recently quit as partner with Baring Private Equity Partners India, is understood to be looking at raising at least a $250 million private equity fund in India. According to private equity industry sources, Subramaniam is scouting for an anchor investor in the US and is understood to have zeroed in on two large funds to anchor. Confirming plans for the new fund, Subramaniam said that discussions are on to raise a fund and the process will be kickstarted early next year. “I am planning a fund of at least $250 million and the corpus may increase to $500 million once the investment strategy is finalised and will depend on infrastructure being a part of that strategy,” he said. Private equity industry sources also detail that Subramaniam is also being sought after to lead the Indian operations of a large European private equity fund which is planning to enter India soon. Subramaniam, a chartered and cost accountant, quit Baring in July 2009 after being with the fund since its inception 12 years ago. Baring manages $750 million in all including a $540 million fund which the firm raised last year. Notable investments from Baring include Mphasis, Jyothy Laboratories, JRG Securities and Integra Software besides others. The private equity fund raising scenario in India has been a bit muted this year. According to Venture Intelligence, four India-focussed funds have raised close to $1.2 billion during 2009 and another close to $4.4 billion is in the process of being raised by nine funds.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
The year that was...
The year 2009 saw the industry combating the shadows of global slowdown. A year full of challenges, which kick-started with the Vibrant Gujarat summit, was also a blessing in disguise in some cases especially with pharma companies returning homewards to Gujarat or brain drain from the reputed insitutes like IITs and IIMs being contained for the time being. While acquisitions and mergers gained some momentum in the later half of 2009, some of the special economic zone projects were hit. Companies responded with more innovative solutions while waking up to newer challenges. Problems in land acquisitions continue to remain although the process has been far more peaceful in Gujarat as compared to other states. This can be guaged from the fact that the first Nano by Tata Motors at Sanand got ready this year
Popular Articles
payday loans

Daiichi Sankyo to leverage Ranbaxy's strength in Mexico
Ranbaxy Laboratories today said it would market products from Daiichi Sankyo"s portfolio in Mexico through its Latin America-based subsidiary, Ranbaxy Mexico S A De C V.

TARP repayments don't hurt bank lendings: Geithner
Treasury Secretary Timothy Geithner said US banks weren’t hurting their ability to lend as they repaid the loans of the Troubled Asset Relief Programme and backed away from government assistance.